22
https://pubmed.ncbi.nlm.nih.gov/38113869
This study found that Turkish pediatric nephrologists commonly use rituximab to treat certain kidney conditions, but there is variability in testing and monitoring before and after infusion, highlighting the need for a standardized guideline.
